WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹68 Cr | ₹109 Cr | ₹61 Cr | ₹9.13 Cr | ₹11 Cr |
What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹68 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹9.13 Cr |
| Mar2021 | ₹11 Cr |
How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹68 Cr | -37.42 | |
| Mar2024 | ₹109 Cr | 78.73 | |
| Mar2023 | ₹61 Cr | 567.74 | |
| Mar2022 | ₹9.13 Cr | -20.30 | |
| Mar2021 | ₹11 Cr | - | |
Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,653.0 Cr | -3.3% | -2% | -5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -3.3% |
-2% |
-5.7% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses